Literature DB >> 2938278

The prevalence of locomotor disability and handicap in the Cape Peninsula. Part I. The coloured population of Bishop Lavis.

P B Disler, E Jacka, A R Sayed, M R Rip, S Hurford, P Collis.   

Abstract

A door-to-door survey to identify the locomotor disabled was carried out on 33.35% of the so-called coloured population in a low socio-economic area of the Cape Peninsula (9112 people). The prevalence rate of locomotor disability was 11.2/1000. The main causes of disability were illness (44.1%) and trauma (41.2%); the former resulted mostly from cerebrovascular accidents (15.7%) and poliomyelitis (15.7%). Of the disabled persons 11.8% were 15 years of age or less, 57.8% between the ages of 16 and 59 years and 30.4% were more than 60 years. Of those in the working-age group 15% were employed. Few of the unemployed had hobbies or interests or had any contact with health or social services.

Entities:  

Mesh:

Year:  1986        PMID: 2938278

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

Review 1.  Systematic review of met and unmet need of surgical disease in rural sub-Saharan Africa.

Authors:  Caris E Grimes; Rebekah S L Law; Eric S Borgstein; Nyeno C Mkandawire; Christopher B D Lavy
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

2.  Musculoskeletal impairment of traumatic etiology in Rwanda: prevalence, causes, and service implications.

Authors:  James I D M Matheson; Oluwarantimi Atijosan; Hannah Kuper; Dorothea Rischewski; Victoria Simms; Christopher Lavy
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Musculoskeletal impairment survey in Rwanda: design of survey tool, survey methodology, and results of the pilot study (a cross sectional survey).

Authors:  Oluwarantimi Atijosan; Hannah Kuper; Dorothea Rischewski; Victoria Simms; Christopher Lavy
Journal:  BMC Musculoskelet Disord       Date:  2007-03-28       Impact factor: 2.362

4.  A national survey of musculoskeletal impairment in Rwanda: prevalence, causes and service implications.

Authors:  Oluwarantimi Atijosan; Dorothea Rischewski; Victoria Simms; Hannah Kuper; Bonaventure Linganwa; Assuman Nuhi; Allen Foster; Chris Lavy
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.